Market Research Logo

Belarus Pharmaceuticals and Healthcare Report Q4 2017

Belarus Pharmaceuticals and Healthcare Report Q4 2017

BMI View:

Despite economic and political tensions, Belarus will continue to represent a market ofconsiderable interest for foreign companies, both innovative and generic makers. The government'sprogramme to reduce import reliance has led to a flurry of investment in domestic initiatives, while theestablishment of the common pharmaceutical market through the Eurasian Economic Union (EAEU) willexpand the range of available medicines. Nevertheless, strict price controls and limited potential for majorshort-term improvement of per-capita spending on healthcare will continue to represent a drag on marketgrowth.

Headline Expenditure Projections

Pharmaceuticals: BYR1.44bn in 2016 (USD743mn) to BYR1.67bn (USD812mn) in 2017; +16.6% inlocal currency terms and 9.3% in US dollar terms.

Healthcare: BYR5.23bn (USD2.71bn) in 2016 to BYR5.96bn (USD2.89bn) in 2017; 14.1% in localcurrency terms and 6.9% in US dollar terms.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Belarus 2015-2021)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Belarus 2013-2021)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Belarus 2013-2021)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Belarus 2013-2021)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Belarus 2013-2021)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Belarus 2013-2021)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Belarus 2013-2021)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Belarus 2013-2021)
OTC Drug Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Belarus 2013-2021)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Belarus 2015-2021)
Table: Pharmaceutical Trade Data And Forecasts local currency (Belarus 2015-2021)
Industry Risk/Reward Index
Central And Eastern Europe Pharmaceuticals: A Mixture Of Opportunities
Regulatory Review
Intellectual Property Issues
Pricing And Reimbursement Regime
Market Overview
Healthcare Sector
Table: Healthcare Resources (Belarus 2011-2016)
Table: Healthcare Personnel (Belarus 2011-2016)
Table: Healthcare Activity (Belarus 2011-2016)
Research And Development
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
Table: Multinational Market Activity
Generic Drugmakers
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Company Profile
Lekpharm
Demographic Forecast
Demographic Outlook
Table: Population Headline Indicators (Belarus 1990-2025)
Table: Key Population Ratios (Belarus 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Belarus 1990-2025)
Table: Population By Age Group (Belarus 1990-2025)
Table: Population By Age Group % (Belarus 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Table: Indicators - Rationale And Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report